Position in ALKS
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$11,244,197
New position
Shares Held
317,992
first reported quarter
Ownership
0.191%
of shares outstanding
% of Portfolio
2.69%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026Spruce Street Capital LP holds $47,889,380 across 2 Drug Manufacturers - Specialty & Generic names. ALKS ranks #2 (23.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
761,063 | $36,645,183 | |
| 2 | ALKS |
Alkermes plc.
This page
|
317,992 | $11,244,197 |
All Filings in ALKS
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $11,244,197 | 317,992 | Shares | Sole | 2026-05-14 | |
| No filing history on record for this holder in this stock. | ||||||